Refractory immune thrombocytopenia treated with low-dose decitabine combined with recombinant human thrombopoietin or eltrombopag: Two case reports
Low-dose decitabine combined with recombinant human thrombopoietin or eltrombopag may exert a synergistic effect in the treatment of refractory ITP.
Authors
- Minxia M. He
- Yani Xu (ORCID: https://orcid.org/0000-0002-7467-0256)
- Xiaofeng Xu (ORCID: https://orcid.org/0000-0002-3998-9245)
- Yu‐Xia Jiang (ORCID: https://orcid.org/0009-0008-4883-3411)
- Huifang Jiang (ORCID: https://orcid.org/0000-0003-4087-205X)
- Haiying Wu (ORCID: https://orcid.org/0000-0002-8943-5267)
Institutions
- Tongde Hospital of Zhejiang Province (CN)
- Zhejiang Hospital (CN)
- Hangzhou Red Cross Hospital (CN)
Publication Details
- Journal
- Medicine
- Published
- 2025-02-07
- DOI
- https://doi.org/10.1097/md.0000000000041449
- Citations
- 1
- Primary Topic
- Platelet Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.77